Stephen F. Flaim
Chief Executive Officer at OncoFluor, Inc.
Profile
Stephen F.
Flaim is the founder of CardioCreate, Inc. He is currently the Chairman, President & Chief Executive Officer at OncoFluor, Inc. and also serves as the Director at Angel Capital Association.
Stephen F. Flaim active positions
Companies | Position | Start |
---|---|---|
OncoFluor, Inc.
OncoFluor, Inc. Electronic Equipment/InstrumentsElectronic Technology OncoFluor, Inc. provides methods for imaging and treating of organs and tissues. The company is headquartered in Coronado, CA | Chief Executive Officer | - |
Angel Capital Association
Angel Capital Association Financial ConglomeratesFinance Angel Capital Association provides investment services. The CEO of the American company is Patrick Gouhin. | Director/Board Member | 22/01/2014 |
Former positions of Stephen F. Flaim
Companies | Position | End |
---|---|---|
CardioCreate, Inc.
CardioCreate, Inc. BiotechnologyHealth Technology CardioCreate, Inc. develops cardiac stem cell therapies. Its stem cell therapies are used to repair and replace damaged heart tissues after a heart attack. The company was founded by Ned Israelsen, Stephen F. Flaim and Mark A. Sussman and is headquartered in San Diego, CA. | Chief Executive Officer | 01/06/2020 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
OncoFluor, Inc.
OncoFluor, Inc. Electronic Equipment/InstrumentsElectronic Technology OncoFluor, Inc. provides methods for imaging and treating of organs and tissues. The company is headquartered in Coronado, CA | Electronic Technology |
Angel Capital Association
Angel Capital Association Financial ConglomeratesFinance Angel Capital Association provides investment services. The CEO of the American company is Patrick Gouhin. | Finance |
CardioCreate, Inc.
CardioCreate, Inc. BiotechnologyHealth Technology CardioCreate, Inc. develops cardiac stem cell therapies. Its stem cell therapies are used to repair and replace damaged heart tissues after a heart attack. The company was founded by Ned Israelsen, Stephen F. Flaim and Mark A. Sussman and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Stephen F. Flaim